data on fda approved therapy for relapsed/refractory sclc
Published 3 years ago • 217 plays • Length 7:39
Download video MP4
Download video MP3
Similar videos
-
6:00
treatment of relapsed/refractory sclc
-
8:15
use of i/o regimen in relapsed/refractory sclc
-
2:34
i-o strategies in relapsed/refractory sclc
-
6:02
immunotherapy in relapsed-refractory sclc
-
1:27
fda approval of atezolizumab for nsclc
-
1:18
dr. dean on fda approved drugs for patients with relapsed mcl
-
2:18
dr owonikoko on the impact of the fda approval of tarlatamab in es-sclc
-
1:36
fda approval of durvalumab for stage iii unresectable nsclc
-
12:53
fda approval in sclc, partial hold in myeloma trials, nccn guideline update in crc, and more
-
1:33
dr. borghaei on the fda approval of nivolumab in small cell lung cancer
-
10:01
fda approvals in sclc and a biosimilar, and japanese approvals in aml, ntrk tumors, and more
-
1:07
dr. subbiah on the fda approval of pralsetinib in ret nsclc
-
3:01
new fda approved treatment for lung cancer (fcl july 2nd 2020)
-
1:28
dr. forster on recent data with lurbinectedin in sclc
-
8:12
fda approvals in hcc, sclc, and nsclc, priority review in rare blood cancer, and more
-
3:02
dr. ou on the fda approval of pembrolizumab in sclc
-
1:22
dr. horn on updated data from impower133 in small cell lung cancer
-
9:54
fda approval in nsclc, priority review designation in sclc, crl to biosimilar, and more
-
7:23
fda approval in nsclc, priority review in sclc, 2018 sabcs highlights, and more
Clip.africa.com - Privacy-policy